AGLIETTA, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 275
EU - Europa 163
AS - Asia 41
SA - Sud America 2
Totale 481
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 271
DE - Germania 50
GB - Regno Unito 47
SE - Svezia 21
IT - Italia 15
SG - Singapore 14
RU - Federazione Russa 10
HK - Hong Kong 9
CN - Cina 8
IN - India 5
UA - Ucraina 5
FR - Francia 4
TR - Turchia 4
BE - Belgio 3
CA - Canada 3
FI - Finlandia 3
BG - Bulgaria 2
BR - Brasile 2
LT - Lituania 2
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
Totale 481
Salva come PNG Salva come JPEG
Città #
Southend 38
Fairfield 33
Houston 33
Ashburn 29
Santa Clara 24
Woodbridge 24
Cambridge 19
Chandler 17
Wilmington 15
Ann Arbor 14
Nyköping 12
Seattle 12
Singapore 12
Hong Kong 8
Dearborn 7
Jacksonville 5
Modena 5
Eugene 4
Izmir 4
Brussels 3
Helsinki 3
San Diego 3
Toronto 3
Beijing 2
Bremen 2
Florence 2
Guntur 2
Hyderabad 2
Milan 2
Moscow 2
Nanjing 2
New York 2
Parma 2
Princeton 2
Sofia 2
Albuquerque 1
As 1
Bangalore 1
Boardman 1
Central 1
Kuala Lumpur 1
London 1
Los Angeles 1
Nanning 1
Panama City 1
Philadelphia 1
Prescot 1
San Jose 1
Stanford 1
São Paulo 1
Totale 366
Salva come PNG Salva come JPEG
Nome #
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program 274
Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients 213
Totale 487
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.637
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202064 0 0 0 0 0 0 19 11 12 7 8 7
2020/202176 10 3 7 7 7 1 13 7 3 8 5 5
2021/202251 1 12 1 5 1 4 3 5 4 1 9 5
2022/202361 9 9 5 4 11 3 4 5 4 2 3 2
2023/202433 0 2 1 3 8 1 7 4 0 1 3 3
2024/202546 8 0 3 8 16 11 0 0 0 0 0 0
Totale 487